Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: Mining of microarray data by logic classification and feature selection

Journal of Alzheimer's Disease

Volumn 24, Issue 4, 2011, Pages 721-738

  Arisi, Ivan ^a   D'Onofrio, Mara ^a   Brandi, Rossella ^a   Felsani, Armando ^b,c   Capsoni, Simona ^d,g   Drovandi, Guido ^e,f   Felici, Giovanni ^e   Weitschek, Emanuel ^e,f   Bertolazzi, Paola ^e   Cattaneo, Antonino ^d,g  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b CNR   (Italy)

^c Genomnia   (Italy)

^d SCUOLA NORMALE SUPERIORE   (Italy)

^e Istituto di Analisi Dei Sistemi Ed Informatica Antonio Ruberti   (Italy)

^f ROMA TRE UNIVERSITY   (Italy)

^g EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

Alzheimer's disease; biomarkers; data mining; gene expression; microarray; mouse models; nerve growth factor; statistical data interpretation

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; PEPTIDE TRANSPORTER 2; GENETIC MARKER;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; MICROARRAY ANALYSIS; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; BRAIN LEVEL; C57BL MOUSE; COMPARATIVE STUDY; DATA MINING; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES;

ALZHEIMER DISEASE; ANIMALS; BRAIN CHEMISTRY; DATA MINING; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 79959262895     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-101881     Document Type: Article

References (62)

1. Blennow K, Hampel H,Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6, 131-144.
2. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K (2010) Biomarkers for Alzheimers disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9, 560-574.
3. Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A (2000) Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci U S A 97, 6826-6831. (Pubitemid 30412799)
4. Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, Rossi G, Berardi N, Cattaneo A (2000) Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 20, 2589-2601. (Pubitemid 30220346)
5. Capsoni S, Giannotta S, Cattaneo A (2002) Beta-amyloid plaques in a model for sporadic Alzheimers disease based on transgenic anti-nerve growth factor antibodies. Mol Cell Neurosci 21, 15-28. (Pubitemid 35178496)
6. Houeland G, Romani A, Marchetti C, Amato G, Capsoni S, Cattaneo A, Marie H (2010) Transgenic mice with chronic NGF deprivation and Alzheimers disease-like pathology display hippocampal region-specific impairments in short-and long-term plasticities. J Neurosci 30, 13089-13094.
7. Lagostena L, Rosato-Siri M, DOnofrio M, Brandi R, Arisi I, Capsoni S, Franzot J, Cattaneo A, Cherubini E (2010) In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction. J Neurosci 30, 885-893.
8. Origlia N, Capsoni S, Domenici L, Cattaneo A (2006) Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice. J Alzheimers Dis 9, 59-68.
9. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, Cattaneo A (2005) Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci U S A 102, 3811-3816. (Pubitemid 40360709)
10. Capsoni S, Cattaneo A (2006) On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimers disease. Cell Mol Neurobiol 26, 619-633.
11. Cattaneo A, Capsoni S, Paoletti F (2008) Towards non invasive nerve growth factor therapies for Alzheimers disease. J Alzheimers Dis 15, 255-283.
12. DOnofrio M, Arisi I, Brandi R, Di Mambro A, Felsani A, Capsoni S, Cattaneo A (2009) Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice. Neurobiol Aging. DOI:10.1016/j.neurobiolaging.2009. 05.023
13. Bertolazzi P, Felici G, Festa P (2009) Logic based methods for SNPs tagging and reconstruction. Computers Operations Res 37, 1419-1426.
14. Bertolazzi P, Felici G, Lancia G (2010) Application of feature selection and classification to computational molecular biology. In: Biological Data Mining, Chen JK, Lonardi S, eds, Chapman & Hall CRC Press, Florida, USA, pp. 257-293.
15. Bertolazzi P, Felici G,WeitschekE(2009) Learning to classify species with barcodes.BMCBioinformatics 10(Suppl 14), S7.
16. Felici G, Truemper K (2002) A Minsat approach for learning in logic domains. INFORMS J Computing 14, 20-36.
17. Cattaneo A, Rapposelli B, Calissano P (1988) Three distinct types of monoclonal antibodies after long-term immunization of rats with mouse nerve growth factor. J Neurochem 50, 1003-1010.
18. Covaceuszach S, Cassetta A, Konarev PV, Gonfloni S, Rudolph R, Svergun DI, Lamba D, Cattaneo A (2008) Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody. J Mol Biol 381, 881-896.
19. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98, 5116-5121. (Pubitemid 32397092)
20. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57.
21. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J (2006) TM4 microarray software suite. Methods Enzymol 411, 134-193.
22. Felici G, Truemper K (2005) The Lsquare System for Mining Logic Data, Idea Group Reference.
23. Allen Brain Atlas (http://www.alleninstitute.org/index.html).
24. Jones AR, Overly CC, Sunkin SM (2009) The allen brain atlas: 5 years and beyond. Nat Rev Neurosci 10, 821-828.
25. Blalock E (2007) Transcription profiling of human hippocampus samples from patients with Alzheimers disease of varying severity. The ArrayExpress Archive, E-GEOD-1297, Public Release Date August 14, 2007.
26. McLennanAG(2006) The Nudix hydrolase superfamily. Cell Mol Life Sci 63, 123-143. (Pubitemid 43100287)
27. Formentini L, Macchiarulo A, Cipriani G, Camaioni E, Rapizzi E, Pellicciari R, Moroni F, Chiarugi A (2009) Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure. J Biol Chem 284, 17668-17676.
28. Eisfeld J, Luckhoff A (2007) Trpm2. Handb Exp Pharmacol, 237-252.
29. Atamna H, Frey WH 2nd (2007) Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimers disease. Mitochondrion 7, 297-310. (Pubitemid 47300175)
30. Pavlov PF, Wiehager B, Sakai J, Frykman S, Behbahani H, Winblad B, Ankarcrona M (2011) Mitochondrial {gamma}-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein. FASEB J 25, 78-88.
31. Smith SA, Holik PR, Stevens J, Melis R, White R, Albertsen H (1995) Isolation and mapping of a gene encoding a novel human ADP-ribosylation factor on chromosome 17q12-q21. Genomics 28, 113-115.
32. Amaral PP, Neyt C,Wilkins SJ, Askarian-Amiri ME, Sunkin SM, PerkinsAC,Mattick JS (2009) Complex architecture and regulated expression of the Sox2ot locus during vertebrate development. RNA 15, 2013-2027.
33. Shen H, Keep RF, Hu Y, Smith DE (2005) PEPT2 (Slc15a2)-mediated unidirectional transport of cefadroxil from cerebrospinal fluid into choroid plexus. J Pharmacol Exp Ther 315, 1101-1108. (Pubitemid 41635396)
34. Teuscher NS, Shen H, Shu C, Xiang J, Keep RF, Smith DE (2004) Carnosine uptake in rat choroid plexus primary cell cultures and choroid plexus whole tissue from PEPT2 null mice. J Neurochem 89, 375-382. (Pubitemid 38495986)
35. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201.
36. Capsoni S, Tiveron C, Amato G, Vignone D, Cattaneo A (2010) Peripheral neutralization of nerve growth factor induces immunosympathectomy and central neurodegeneration in transgenic mice. J Alzheimers Dis 20, 527-546.
37. Williams C (2009) Transcription profiling of human Alzheimers disease patients to identify genes regulating synaptic function and neuroplasticity in incipient AD. The ArrayExpress Archive, E-GEOD-12685, Public Release Date January 17, 2009.
38. Korade Z,Kenchappa RS, Mirnics K, Carter BD (2009) NRIF is a regulator of neuronal cholesterol biosynthesis genes. J Mol Neurosci 38, 152-158.
39. Yan C, Mirnics ZK, Portugal CF, Liang Y, Nylander KD, Rudzinski M, Zaccaro C, Saragovi HU, Schor NF (2005) Cholesterol biosynthesis and the pro-apoptotic effects of the p75 nerve growth factor receptor in PC12 pheochromocytoma cells. Brain Res Mol Brain Res 139, 225-234. (Pubitemid 41317935)
40. Mulligan MK, Ponomarev I, Boehm SL 2nd, Owen JA, Levin PS, Berman AE, BlednovYA, Crabbe JC,WilliamsRW,Miles MF, Bergeson SE (2008) Alcohol trait and transcriptional genomic analysis of C57BL/6 substrains. Genes Brain Behav 7, 677-689.
41. Aznarez I, Barash Y, Shai O, He D, Zielenski J, Tsui LC, Parkinson J, Frey BJ, Rommens JM, Blencowe BJ (2008) A systematic analysis of intronic sequences downstream of 5-splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation. Genome Res 18, 1247-1258.
42. Bronner I (2009) Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways. The ArrayExpress Archive, E-mexp-2280, Public Release Date August 3, 2009.
43. Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimers disease brain: potential causes and consequences involving amyloid beta-peptideassociated free radical oxidative stress. Free Radic Biol Med 32, 1050-1060. (Pubitemid 34603342)
44. Calabrese V, Guagliano E, Sapienza M, Mancuso C, ButterfieldDA, StellaAM(2006) Redox regulation of cellular stress response in neurodegenerative disorders. Ital J Biochem 55, 263-282.
45. Lovell MA, Xie C, Gabbita SP, Markesbery WR (2000) Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimers disease brain. Free Radic Biol Med 28, 418-427. (Pubitemid 30110658)
46. Mancuso C, Bates TE, Butterfield DA, Calafato S, Cornelius C, De Lorenzo A, Dinkova Kostova AT, Calabrese V (2007) Natural antioxidants in Alzheimers disease. Expert Opin Investig Drugs 16, 1921-1931.
47. Perry G, Castellani RJ, Hirai K, Smith MA (1998) Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimers Dis 1, 45-55.
48. Eliceiri GL (2006) The vertebrate E1/U17 small nucleolar ribonucleoprotein particle. J Cell Biochem 98, 486-495. (Pubitemid 43727171)
49. Yoo AS, Staahl BT, Chen L, Crabtree GR (2009) MicroRNAmediated switching of chromatin-remodelling complexes in neural development. Nature 460, 642-646.
50. Ding W, Li C, Hu T, Graves-Deal R, Fotia AB, Weissman AM, Coffey RJ (2008) EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation. Proc Natl Acad Sci U S A 105, 13433-13438.
51. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4, P3.
52. Perry VH, OConnor V (2008) C1q: the perfect complement for a synaptic feast? Nat Rev Neurosci 9, 807-811.
53. Raurell I, Codina M, Casagolda D, Del Valle B, Baulida J, de HerrerosAG, DunachM(2008) Gamma-secretase-dependent and -independent effects of presenilin1 on beta-catenin.Tcf-4 transcriptional activity. PLoS One 3, e4080.
54. Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD, Ertekin-Taner N, Crook JE, DicksonDW, Petersen RC, Graff-Radford NR, Younkin SG (2009) Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimers disease. Nat Genet 41, 192-198.
55. Ko MH, Puglielli L (2009) Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels. J Biol Chem 284, 2482-2492.
56. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32, 591-601.
57. Manzo F, Tambaro FP, Mai A, Altucci L (2009) Histone acetyltransferase inhibitors and preclinical studies. Expert Opin Ther Path 19, 761-774.
58. Narayan P, DragunowM(2010) Pharmacology of epigenetics in brain disorders. Br J Pharmacol 159, 285-303.
59. Goggins M, Scott JM,WeirDG(1999) Methylation of cortical brain proteins from patients with HIV infection. Acta Neurol Scand 100, 326-331. (Pubitemid 29482558)
60. Zhou XW, Gustafsson JA, Tanila H, Bjorkdahl C, Liu R, Winblad B, Pei JJ (2008) Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiol Dis 31, 386-394.
61. Ferrer I (2009) Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimers disease. J Bioenerg Biomembr 41, 425-431.
62. Capsoni S, Tiveron C, Vignone D, Amato G, Cattaneo A (2010) Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration. Proc Natl Acad Sci U S A 107, 12299-12304.